|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/16/24 Skinvisible, Inc. 10-K 12/31/23 46:2.7M Edgar Einsteins, Inc./FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 703K
7: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
10: R1 Cover HTML 78K
11: R2 Consolidated Balance Sheets (Audited) HTML 115K
12: R3 Consolidated Balance Sheets (Audited) HTML 29K
(Parenthetical)
13: R4 Consolidated Statements of Operations (Audited) HTML 90K
14: R5 Consolidated Statements of Stockholders' Deficit HTML 35K
(Audited)
15: R6 Consolidated Statements of Cash Flows (Audited) HTML 86K
16: R7 1. Description of Business and History HTML 20K
17: R8 2. Basis of Presentation and Going Concern HTML 21K
18: R9 3. Summary of Significant Policies HTML 37K
19: R10 4. Intangible and Other Assets HTML 19K
20: R11 5. Related Party Transactions HTML 36K
21: R12 6. Notes Payable HTML 44K
22: R13 8. Commitments and Contingencies HTML 21K
23: R14 9. Income Taxes HTML 31K
24: R15 10. Stockholders? Deficit HTML 23K
25: R16 11. Subsequent Events HTML 17K
26: R17 1. Description of Business and History (Policies) HTML 20K
27: R18 2. Basis of Presentation and Going Concern HTML 22K
(Policies)
28: R19 3. Summary of Significant Policies (Policies) HTML 64K
29: R20 5. Related Party Transactions (Tables) HTML 32K
30: R21 6. Notes Payable (Tables) HTML 37K
31: R22 9. Income Taxes (Tables) HTML 23K
32: R23 2. Basis of Presentation and Going Concern HTML 27K
(Details Narrative)
33: R24 3. Summary of Significant Policies (Details HTML 24K
Narrative)
34: R25 4. Intangible and Other Assets (Details Narrative) HTML 21K
35: R26 4. RELATED PARTY TRANSACTIONS - Schedule of HTML 67K
Convertible Notes Payable Related Party (Details)
36: R27 7. CONVERTIBLE NOTES PAYABLE - Schedule of HTML 72K
Convertible Notes Payable (Details)
37: R28 6. Notes Payable (Details Narrative) HTML 24K
38: R29 8. Commitments and Contingencies (Details HTML 24K
Narrative)
39: R30 9. INCOME TAXES - Deferred Tax Assrts and HTML 27K
Liabilities (Details)
40: R31 9. Income Taxes (Details Narrative) HTML 25K
41: R32 10. Stockholders? Deficit (Details Narrative) HTML 24K
43: XML IDEA XML File -- Filing Summary XML 77K
46: XML XBRL Instance -- skvi10k_123123_htm XML 394K
42: EXCEL IDEA Workbook of Financial Report Info XLSX 64K
3: EX-101.CAL XBRL Calculations -- skvi-20231231_cal XML 94K
4: EX-101.DEF XBRL Definitions -- skvi-20231231_def XML 138K
5: EX-101.LAB XBRL Labels -- skvi-20231231_lab XML 429K
6: EX-101.PRE XBRL Presentations -- skvi-20231231_pre XML 344K
2: EX-101.SCH XBRL Schema -- skvi-20231231 XSD 68K
44: JSON XBRL Instance as JSON Data -- MetaLinks 228± 325K
45: ZIP XBRL Zipped Folder -- 0001663577-24-000119-xbrl Zip 193K
| CERTIFICATIONS |
I, Terry Howlett, certify that;
| 1. | I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2023 of Skinvisible, Inc. (the “registrant”); |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: April 16, 2024
/s/ Terry Howlett
By: Terry Howlett
Title: Chief Executive Officer
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/16/24 | |||
| For Period end: | 12/31/23 | NT 10-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/22/19 Skinvisible, Inc. 8-K:1,8,9 10/17/19 2:43K Edgar Einsteins, Inc./FA 1/02/19 Skinvisible, Inc. 8-K:3,5,9 1/02/19 2:44K Edgar Einsteins, Inc./FA 3/29/18 Skinvisible, Inc. 8-K:1,9 3/26/17 13:763K Edgar Einsteins, Inc./FA 9/12/08 Skinvisible, Inc. 8-K:3,9 9/10/08 2:28K Galaxy Gaming, Inc. 4/14/05 Skinvisible, Inc. 10KSB 12/31/04 5:646K Clark Corp Law Group LLP |